等待開盤 09-11 09:30:00 美东时间
+0.170
+2.92%
H.C. Wainwright analyst Robert Burns reiterated a Hold rating on Replimune Grou...
09-08 20:25
HC Wainwright & Co. analyst Robert Burns reiterates Replimune Group (NASDAQ:REPL) from Neutral to Neutral.
09-08 20:14
Replimune Group ( ($REPL) ) has provided an update. On September 3, 2025, Repli...
09-05 04:37
Replimune Group has scheduled a Type A meeting with the FDA to discuss the complete response letter (CRL) regarding its Biologics License Application (BLA) for RP1 in combination with nivolumab for advanced melanoma. The company submitted a briefing book addressing the CRL points, including patient population criteria, PD-1 resistance, and literature use, and provided additional analyses of BLA data and phase 3 trial design. CEO Sushil Patel emph...
09-02 12:00
Repligen Corporation will attend three investor conferences in September 2025. Olivier Loeillot, CEO, will participate in discussions at the Wells Fargo Healthcare Conference on September 4 in Boston and at the Bank of America Global Healthcare Conference on September 25 in London. Jason Garland, CFO, will attend 1x1 meetings at the Deutsche Bank Healthcare Summit on September 10 in New York. Live webcasts will be available via Repligen’s Investo...
08-22 11:30
Shares of KULR Technology Group, Inc. (NYSE:KULR) rose sharply in pre-market tr...
08-15 20:46
Gainers IO Biotech (NASDAQ:IOBT) stock rose 52.5% to $2.76 during Monday's pre...
08-11 20:08
周一美股盘前,多家生物科技公司股价出现下跌。此前有报道称,曾被解职的美国食品药品监督管理局(FDA)疫苗监管官员Vinay Prasad将重返该机构。
08-11 19:42
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration vaccine regulator Vinay Prasad will return to the agency. Prasad, who had o...
08-11 18:25